GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (BSP:C1CO34) » Definitions » Cyclically Adjusted Revenue per Share

Cencora (BSP:C1CO34) Cyclically Adjusted Revenue per Share : R$3,019.05 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Cencora Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cencora's adjusted revenue per share for the three months ended in Mar. 2025 was R$1,113.488. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$3,019.05 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Cencora's average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 13.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cencora was 16.90% per year. The lowest was 13.00% per year. And the median was 15.00% per year.

As of today (2025-05-30), Cencora's current stock price is R$825.00. Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was R$3,019.05. Cencora's Cyclically Adjusted PS Ratio of today is 0.27.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.36. The lowest was 0.14. And the median was 0.19.


Cencora Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Cencora's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Cyclically Adjusted Revenue per Share Chart

Cencora Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,815.62 2,055.58 2,450.21 2,506.26 3,253.42

Cencora Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,610.50 2,964.52 3,253.42 3,454.65 3,019.05

Competitive Comparison of Cencora's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.


;
;

Cencora Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cencora's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1113.488/134.9266*134.9266
=1,113.488

Current CPI (Mar. 2025) = 134.9266.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 221.708 100.684 297.111
201509 326.410 100.392 438.696
201512 314.180 99.792 424.794
201603 292.776 100.470 393.183
201606 280.827 101.688 372.620
201609 269.267 101.861 356.675
201612 288.360 101.863 381.960
201703 262.585 102.862 344.438
201706 287.452 103.349 375.281
201709 276.854 104.136 358.715
201712 301.910 104.011 391.648
201803 302.628 105.290 387.812
201806 368.476 106.317 467.633
201809 409.042 106.507 518.189
201812 411.922 105.998 524.343
201903 391.361 107.251 492.352
201906 413.024 108.070 515.667
201909 439.455 108.329 547.351
201912 473.361 108.420 589.088
202003 559.475 108.902 693.177
202006 572.581 108.767 710.291
202009 651.510 109.815 800.493
202012 653.241 109.897 802.021
202103 668.038 111.754 806.555
202106 642.736 114.631 756.531
202109 737.582 115.734 859.896
202112 798.404 117.630 915.807
202203 677.470 121.301 753.569
202206 715.951 125.017 772.703
202209 763.959 125.227 823.136
202212 798.870 125.222 860.783
202303 809.091 127.348 857.242
202306 794.962 128.729 833.237
202309 836.829 129.860 869.482
202312 877.006 129.419 914.325
202403 846.741 131.776 866.984
202406 999.444 132.554 1,017.335
202409 1,105.123 133.029 1,120.888
202412 1,273.522 133.157 1,290.446
202503 1,113.488 134.927 1,113.488

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Cencora  (BSP:C1CO34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cencora's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=825.00/3019.05
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.36. The lowest was 0.14. And the median was 0.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cencora Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Cencora's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora Business Description

Industry
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora Headlines

No Headlines